Skip Navigation
Skip to contents

ACC : Acute and Critical Care

OPEN ACCESS
SEARCH
Search
Advanced Search
mobile menu button

Best practice

Page Path
HOME > About > Best practice
About

Posted in March, 2019

As an open access journal, ACC will follow the Principles of Transparency and Best Practice in Scholarly Publishing (https://doaj.org/bestpractice) developed by Committee on Publication Ethics (COPE), the Directory of Open Access Journals (DOAJ), the Open Access Scholarly Publishers Association (OASPA), and the World Association of Medical Editors (WAME).


Table of Contents

1. Website

The URL address of the official web site is http://www.accjournal.org.

1) “Aims & Scope” statement

https://www.accjournal.org/about/index.php

Acute and Critical Care (abbreviated as Acute Crit Care, ACC) is a peer-reviewed scientific journal that publishes current works and ideas in critical and intensive care medicine. It informs clinical and experimental results and evidences for all critical care physicians, critical care nurses, and other healthcare professionals and improves the care of critically ill patients. It is a medium dedicated to basic, experimental, translational research as well as clinical studies relating to all fields of critical illness. It publishes journals quarterly. All or part of the Journal is indexed by Emerging Sources Citation Index (ESCI), PubMed, PubMed Central (PMC), Scopus, KCI (Korea Citation Index), KoreaMed, KoMCI (Korean Medical Citation Index), DOAJ (Directory of Open Access Journals), EBSCO, Crossref, Google Scholar, ScienceCentral, and the Journal can also can be downloaded from the homepage of the Korean Society of Critical Care Medicine (http://www.ksccm.org) and the Journal’s website (http://accjournal.org or http://acuteandcriticalcare.org).

Background

Acute and Critical Care (abbreviated as Acute Crit Care) is the official publication of the Korean Society of Critical Care Medicine (KSCCM), which was founded in 1980. The journal (Taehan Kugup Ŭihakhoe chi ISSN 1229-4802) was first published in 1986. Articles were written in Korean and English until 2013. From 2014, articles were published exclusively in English. In 2018, the name of the official publication of KSCCM was changed from Korean Journal of Critical Care Medicine (1986 ~ 2017) to Acute and Critical Care (Acute Crit Care, ACC, 2018 ~).

2) Readership

This journal is primarily intended for scientific researchers and personnel who work for acute, critical care. However, its readership can be expanded to other positions: students can understand recent trends in acute, critical and intensive care medicine; physicians can obtain recent topics and cases for continuing education; policy makers are able to reflect the results of the articles to nation-wide public health and science promotion policies.

3) Authorship criteria

https://www.accjournal.org/authors/authors.php#1

Authorship credit should be based on (1) substantial contributions to the conception and design, acquisition of data, or analysis and interpretation of data; (2) drafting the article or revising it critically for important intellectual content; (3) final approval of the version to be published; and (4) agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Authors should meet these four conditions. If the number of authors is greater than six, a list should be included of each author’s role for the submitted paper. Policies on research and publication ethics that are not stated in the Instructions can be found in the Guidelines on Good Publication (http://publicationethics.org/) or Good Publication Practice Guidelines for Medical Journals (http://kamje.or.kr/).

4) Duplicate submission and redundant publication

https://www.accjournal.org/authors/authors.php#1

All submitted manuscripts should be original and should not be under consideration by other scientific journals for publication at the same time. Any part of the accepted manuscript should not be duplicated in any other scientific journal without the permission of the Editorial Board. It is mandatory that all authors resolve any copyright issues when citing a figure or table from another journal that is not open-access. If duplicate publications related to papers in this journal are detected, the authors will be announced in the Journal and their institutes will be informed, and there will also be penalties for the authors.

5) pISSN: 2586-6052    eISSN: 2586-6060

2. Name of journal

The official journal title is Acute and Critical Care. The journal’s abbreviated title is Acute Crit Care.

3. Peer review process

http://www.accjournal.org/authors/peer_review_publication.php#1

Adoption of peer review

If the manuscript does not fit the aims and scope of the Journal or does not adhere to the Instructions for Authors, it may be returned to the author immediately after receipt and without a review. Before reviewing, all submitted manuscripts are inspected through a Similarity Check powered by iThenticate, a plagiarism-screening tool. If too high a degree of similarity is found, the Editorial Board will conduct a more detailed content screening.

Peer-review methods

http://www.accjournal.org/authors/peer_review_publication.php#3

ACC uses double-blind review, which means that both the reviewer’s and author’s identities are concealed throughout the review process. Screening before the review period typically lasts one week. The first decision is usually made within three weeks after completion of the review. The Editorial Board’s decision after the review will be one of following: Accept, Minor revision, Major revision, or Rejection. The Editorial Board may request that the authors revise the manuscript according to the reviewers’ comments. The authors should do their best to revise the manuscript according to such requests. If the reviewer's opinion is not acceptable or deemed possible to misinterpret data, the author should reasonably indicate this issue. After revising the manuscript, the author should upload the revised files with a reply to each item of the reviewer's commentary. The author's revisions should be completed within 30 days after the request. If the revised manuscript is not received by the due date, the Editorial Board will notify the author. For an extension of the revision period beyond 30 days, the author should negotiate with the Editorial Board. The manuscript review process can be provided for up two rounds. However, the Editorial Board may consider further reviews according to the reviewers’ wishes. The Editorial Board will make a final decision on the approval of the submitted manuscript for publication and can request further corrections, revisions, and deletions of the article’s text if necessary. Statistical editing is also performed if the data requires professional statistical review by a statistician.

4. Ownership and management

1) Information about ownership

This journal is owned by the publisher, the Korean Society of Critical Care Medicine.
http://www.ksccm.org.

2) Management team

http://www.accjournal.org/about/management_team.php

• Journal Manager: Jae Hwa Cho, Yonsei University, Korea, Editor-in-Chief of Acute and Critical Care
• Manager of the Review Process: Moo Suk Park, Yonsei University, Korea, Associate Editor of Acute and Critical Care
• Statistics Editor: Young Ju Suh, Inha University, Korea
• Manuscript Editors: Mijoo Chung, Infolumi, Korea
• Layout Editor: Eun Mi Jeong, M2PI, Korea
• English Editor: Tina Tague, Eworld Editing, Korea
• Website and JATS XML File Producers: Jeonghee Im, M2PI, Korea

5. Governing body

The governing body is the Journal's Editorial Board.

6. Editorial team and contact information

http://www.accjournal.org/about/editorial.php

Editor-in-Chief
Jae Hwa Cho Yonsei University, Korea
Deputy Editor
Moo Suk Park Yonsei University, Korea
Associate Editors
Ah-reum Cho Pusan National University, Korea
Hwa Jin Cho Chonnam National University Children’s Hospital and Medical School, Korea
Yeonsoo Jang Yonsei University, Korea
Kyeongman Jeon Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul
Kwangwook Jo The Catholic University of Korea, Seoul, Korea
Jeehoon Kang Seoul National Univeristy, Korea
Youngjoon Kang Jeju National University, Korea
Do Wan Kim Chonnam National University Hospital, Korea
Dohhyung Kim Dankook University, Korea
Eun Young Kim The Catholic University of Korea, Seoul, Korea
Min-Seok Kim University of Ulsan College of Medicine, Asan Medical Center, Korea
Kwangha Lee Pusan National University, Korea
Dong Hyun Lee Dong-A University College of Medicine, Busan, Korea
SeungYon Park Jeonbuk National University Medical School, Korea
Dong-Ick Shin Chungbuk National University, Korea
Inae Song Seoul National University, Korea
Editorial Board
Pravin Amin Bombay Hospital, India
Djillali Annane University of Paris, France
Lluis Blanch Hospital de Sabadell, Spain
Jin Sun Cho Yonsei University, Korea
Ivor S. Douglas University of Colorado and Denver Health, USA
Wen-Feng Fang Chang Gung University, Taiwan
J. Christopher Farmer Mayo Clinic, USA
Young Joo Han Sungkyunkwan University, Korea
William Hurford University of Cincinnati, USA
Dong Keun Hyun Inha University, Korea
Yumiko Imai Graduate School of Medicine, Akita University, Japan
Jiyeon Kang Dong-A University, Korea
Kyung Won Kim Yonsei University, Korea
Niranjan Kissoon British Columbia Children’s Hospital, Canada
Lauren Sorce Northwestern University, Feinberg School of Medicine
Napplika Kongpolprom King Chulalongkorn Memorial Hospital, Thailand
Jun Wan Lee Chungnam National University Hospital, Korea
Mitchell M. Levy Warren Alpert Medical School at Brown University, USA
Philip D. Lumb Keck Medical Center University of Southern California, USA
Mohd Basri Mat Nor International Islamic University Malaysia, Malaysia
Masaji Nishimura Tokushima University Graduate School, Japan
Yasuhiro Norisue Tokyo Bay Urayasu Ichikawa Medical Center, Japan
Stephen M. Pastores Memorial Sloan Kettering Cancer Center, USA
Kay Choong See National University Hospital, Singapore
Do Ngoc Son Bach Mai Hospital, Vietnam
Gene Yong Sung Keck Medical Center University of Southern California, USA
Arzu Topeli Hacettepe University Hospitals, Turkey
Ethics Editor
Jae Young Moon Chungnam National University, Korea
Statistical Editor
Young Ju Suh Inha University, Korea
Assistant Editor
So Young Kim Korean Society of Critical Care Medicine
Manuscript Editor
Mijoo Chung Infolumi, Korea
Layout Editor
Eun Mi Jeong M2PI, Korea
English Editor
Tina Tague Eworld Editing, Korea
Website and JATS XML File Producer
Jeonghee Im M2PI, Korea

Contact information

http://www.accjournal.org/about/contact.php

Acute and Critical Care Editorial Office

  • #805-806, Yongseong Biztel, 109 Hangang-daero, Yongsan-gu, Seoul 04376, Korea
  • Tel: +82-2-2077-1533
  • Fax: +82-2-2077-1535
  • E-mail: acc@accjournal.org

7. Copyright and licensing

http://www.accjournal.org/about/open_access.php

1) Copyright policy

Copyright in all published material is owned by the Korean Society of Critical Care Medicine. Authors must agree to transfer copyright during the submission process. The corresponding author is responsible for submitting the copyright transfer agreement to the publisher.

2) Licensing information

ACC is an open-access journal. Articles are distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited. Author(s) do not need to obtain permission for the use of tables or figures published in ACC from other journals, books, or media for scholarly and educational purposes. This is in accordance with the Budapest Open Access Initiative definition of open-access.

3) Archiving policy

According to the deposit policy (self-archiving policy) of Sherpa/Romeo(http://www.sherpa.ac.uk), authors cannot archive pre-print (i.e., pre-refereeing), but they can archive post-print (i.e., final draft post-refereeing). Authors can archive the publisher's version/PDF.

8. Author fees

https://www.accjournal.org/authors/processing_charge.php

There is currently no article processing charge. Authors will be charged an additional fee for reprints or color prints. However, this policy may change in the future.

9. Process for the identification and management of allegations of research misconduct

http://www.accjournal.org/authors/ethics.php#6

When the Journal faces suspected cases of research and publication misconduct such as redundant (duplicate) publication, plagiarism, fraudulent or fabricated data, changes in authorship, undisclosed conflict of interest, ethical problems with a submitted manuscript, a reviewer who has appropriated an author’s idea or data, or complaints against editors, the resolution process will follow that laid out in a flowchart provided by the Committee on Publication Ethics (http://publicationethics.org/resources/flowcharts). Discussions will be held, and decisions will be made by Editorial Board on the suspected cases.

10. Publication ethics

1) Journal policies on authorship and contributorship
http://www.accjournal.org/authors/ethics.php
Authorship credit should be based on 1) substantial contributions to conception and design, acquisition of data, and/or analysis and interpretation of data; 2) drafting the article or revising it critically for important intellectual content; 3) final approval of the version to be published; and 4) agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Every author should meet all four aforementioned conditions. After the initial submission of a manuscript, any changes whatsoever in authorship (adding author(s), deleting author(s), or re-arranging the order of authors) must be explained by a letter to the editor from the authors concerned. This letter must be signed by all authors of the paper. Copyright assignment must also be completed by every author.

If a new author should be added or an author should be deleted after the submission, it is the responsibility of the corresponding author to ensure that the authors concerned are aware of and agree to the change in authorship.

ACC has no responsibility for such changes.

If there is a change in authors, the reasons for the change should be submitted before final decision to the association to secure the consent of the Editor-in-Chief.

Corresponding author and first author: ACC does not allow multiple corresponding authors for each article. Only one author should correspond with the editorial office and readers for one article. ACC does accept notice of equal contribution for the first author when the study was clearly performed by co-first authors.

Correction of authorship after publication: ACC does not correct authorship after publication unless a mistake has been made by the editorial staff. Authorship may be changed before publication, but only after submission, when an authorship correction is requested by all of the authors involved with the manuscript.

2) Handling of complaints and appeals
The journal’s policy is primarily aimed at protecting the authors, reviewers, editors, and the publisher of the Journal. If not described below, the process of handling complaints and appeals follows the guidelines of the Committee of Publication Ethics available from: https://publicationethics.org/appeals

Who complains or makes an appeal?
Submitters, authors, reviewers, and readers may register complaints and appeals in the following cases: falsification, fabrication, plagiarism, duplicate publication, authorship dispute, conflict of interest, ethical treatment of animals, informed consent, bias or unfair/inappropriate competitive acts, copyright, stolen data, defamation, and legal problems. If individuals or institutions wish to inform ACC regarding any improprieties, they can send a letter to the editor. For complaints or appeals, concrete data with answers to all factual questions (who, when, where, what, how, and why) should be provided.

3) Journal policies on conflicts of interest/competing interests
http://www.accjournal.org/authors/ethics.php
The corresponding author must inform the editor of any potential conflicts of interest that could influence the authors’ interpretation of data. Examples of potential conflicts of interest are financial support from or connections to companies, political pressure from interest groups, and academically related issues. In particular, all sources of funding applicable to the study should be explicitly stated.

4) Journal policies on data sharing and reproducibility

Open data policy
For clarification on result accuracy and reproducibility of the results, raw data or analysis data will be deposited to a public repository, for example, Harvard Dataverse (https://dataverse.harvard.edu/dataverse/) after acceptance of the manuscript. Therefore, submission of the raw data or analysis data is mandatory. If the data is already public, the URL of its location or sources should be disclosed. Cases in which data cannot be publicized should be negotiated with the editor. If there are any inquiries on depositing data, authors should contact the editorial office.

Clinical data sharing policy
This journal follows the data sharing policy described in “Data Sharing Statements for Clinical Trials: A Requirement of the International Committee of Medical Journal Editors” (https://doi.org/10.3346/jkms.2017.32.7.1051). As of July 1, 2018 manuscripts submitted to ICMJE journals that report the results of interventional clinical trials must contain a data sharing statement as described below. Clinical trials that begin enrolling participants on or after January 1, 2019 must include a data sharing plan in the trial's registration. The ICMJE's policy regarding trial registration is explained at http://www.icmje.org/recommendations/browse/publishing-and-editorial-issues/clinical-trial-registration.html. If the data sharing plan changes after registration, this should be reflected in the statement submitted and published with the manuscript, and updated in the registry record. All of the authors of research articles that deal with interventional clinical trials must submit a data sharing plan of Examples 1 to 4 in Table 1. Based on the degree of the sharing plan, authors should deposit their data after deidentification and report the DOI of the data and the registered site.

Table 1.   Examples of data sharing statements that fulfill these ICMJE requirementsa

Element Example 1 Example 2 Example 3 Example 4
Will individual participant data be available (including data dictionaries)? Yes Yes Yes No
What data in particular will be shared? All individual participant data collected during the trial, after deidentification. Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices). Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices). Not available
What other documents will be available? Study protocol, statistical analysis plan, informed consent form, clinical study report, analytic code Study protocol, statistical analysis plan, analytic code Study protocol Not available
When will data be available (start and end dates)? Immediately following publication. No end date. Beginning at 3 months and ending at 5 years following the article publication. Beginning at 9 months and ending at 36 months following the article publication. Not applicable
With whom? Anyone who wishes to access the data. Researchers who provide a methodologically sound proposal. Investigators whose proposed use of the data has been approved by an independent review committee (“learned intermediary”) identified for this purpose. Not applicable
For what types of analyses? Any purpose To achieve aims in the approved proposal. For individual participant data meta-analysis. Not applicable
By what mechanism will data be made available? Data are available indefinitely at (link to be included). Proposals should be directed to xxx@yyy. To gain access, data requestors will need to sign a data access agreement. Proposals may be submitted up to 36 months following article publication. After 36 months the data will be available in our University's data warehouse but without investigator support other than deposited metadata. Not applicable
Data are available for 5 years at a third-party website (link to be included). Information regarding submitting proposals and accessing data may be found at (link to be provided).

ICMJE: International Committee of Medical Journal Editors.
aThese examples are meant to illustrate a range of, but not all, data sharing options.

5) Journal's policy on ethical oversight
When the Journal faces suspected cases of research and publication misconduct such as a redundant (duplicate) publication, plagiarism, fabricated data, changes in authorship, undisclosed conflicts of interest, an ethical problem discovered with the submitted manuscript, a reviewer who has appropriated an author’s idea or data, complaints against editors, and other issues, the resolution process will follow the flowchart provided by the Committee on Publication Ethics (http://publicationethics.org/resources/flowcharts). The Editorial Board will discuss the suspected cases and reach a decision. We will not hesitate to publish errata, corrigenda, clarifications, retractions, and apologies when needed.

6) Journal's policy on intellectual property
All published papers become the permanent property of the Korean Society of Critical Care Medicine. Copyrights of all published materials are owned by the Korean Society of Critical Care Medicine.

7) Journal's options for post-publication discussions and corrections
Post-publication discussion is available through letters to the editor. If any readers have a concern about any published articles, they can submit a letter to the editor on the articles. If any errors or mistakes are found in the article, they can be corrected through errata, corrigenda, or retraction.

11. Publishing schedule

http://www.accjournal.org/about/about.php

ACC is published 4 times (February, May, August, November) a year. After acceptance, the e-pub versions of all articles promptly appear on the Journal’s homepage.

12. Access

ACC is an open access journal. Articles are distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited. Author(s) do not need to obtain permission for the use of tables or figures published in ACC from other journals, books, or media for scholarly and educational purposes. This is in accordance with the Budapest Open Access Initiative definition of open-access.

13. Archiving

Archiving is accessible without barrier from the Korea Citation Index (http://kci.go.kr), or the National Library of Korea (http://nl.go.kr) in the event that a journal is no longer published.

14. Revenue sources

The revenue sources of the Journal come from the support of the publisher (Korean Society of Critical Care Medicine), the Korea Government’s support, and advertising rates.

15. Advertising

http://www.accjournal.org/authors/advertising_policies.php

Eligibility of advertised products or services

All products or services should be safe and reliable and not cause any harm to the health and welfare of humans. Advertisements may promote information and technologies relevant for authors, editors, reviewers, and readers. Pharmaceutical products may also be considered.

Advertising is separate from content. Advertisers and sponsors have no advance knowledge of our editorial contents, nor do the editors have advance knowledge of advertisers. Content is never altered, added, or deleted to accommodate advertising. Advertisers and sponsors have no input regarding any of our editorial decisions or advertising policies.

We reserve the right to decline or cancel any advertisement at any time.

Advertisements for pharmaceutical products must conform to all regulations and policies of the Ministry of Food and Drug Safety, Republic of Korea in every respect.

Orders

Any individuals or organizations who are interested in advertising their products or services in the print copies of the Journal or on its website are encouraged to contact the editorial office. The acceptance of advertisements will be discussed by the Editorial Board and will ultimately be approved by the publisher.

Disclaimer

Liability: Neither the publisher nor the editors will be legally liable for advertisements presented in the Journal. In addition, they cannot guarantee the accuracy, completeness, or usefulness of the information provided.

Endorsement: The publisher and the editors do not endorse any products or services that are advertised.

Disclaimer: Neither the publisher nor the authors will be legally liable for any of the content of advertisements.

16. Direct marketing

Journal propagation has been conducted through the Journal’s website and the distribution of an introduction pamphlet. Invitations to submit manuscripts are usually focused on the presenters at conferences, seminars, or workshops if the topic is related to the Journal's aims and scope.

ACC : Acute and Critical Care
© The Korean Society of Critical Care Medicine.